Vimarsana
Biggest News Aggregation in the World

Page 24 - Britain Eakin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Britain Eakin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Britain Eakin Today - Breaking & Trending Today

Fed. Circ. Grills USPTO On Hirshfeld's Power In Arthrex Fight - Vimarsana News

Fed. Circ. Grills USPTO On Hirshfeld's Power In Arthrex Fight

A Federal Circuit panel weighed the latest installment in the ongoing Arthrex saga Wednesday, pressing the government on its argument that a longstanding U.S. Patent and Trademark Office directive authorizes Drew Hirshfeld, the interim leader of the agency, to implement the U.S. Supreme Court's Arthrex remedy.

Source: law360.com
Fed. Circ. Reluctantly Upholds PTAB Panel's Decision - Vimarsana News

Fed. Circ. Reluctantly Upholds PTAB Panel's Decision

With sharp critiques, the Federal Circuit on Thursday upheld a decision by the Patent Trial and Appeal Board's precedent-setting panel allowing DynaEnergetics to amend an oil drilling patent, while affirming the board's initial decision that the original claims were invalid.

Source: law360.com
Patagonia Says Brand Ripped Off TM With Vulgar Designs - Vimarsana News

Patagonia Says Brand Ripped Off TM With Vulgar Designs

Sportswear company Patagonia Inc. has sued the companies behind the "Assholes Live Forever" clothing brand for allegedly selling sweats, T-shirts, hoodies and beanies that use profane, ripped-off versions of Patagonia's trademark.

Source: law360.com
Justices Turn Down Intel's Challenge To PTAB's Fintiv Rule - Vimarsana News

Justices Turn Down Intel's Challenge To PTAB's Fintiv Rule

The U.S. Supreme Court on Monday denied Intel Corp.'s bid to strike down the Patent Trial and Appeal Board's controversial practice of denying patent challenges due to looming trials in district court, dealing another blow to the chorus of tech companies that have tried to kill the policy.

Source: law360.com
Roche Unit Nets $775M Deal In AstraZeneca IP Row - Vimarsana News

Roche Unit Nets $775M Deal In AstraZeneca IP Row

A month after AstraZeneca's Alexion Pharmaceuticals settled claims that its antibody product Ultomiris infringed patents held by Roche-owned rival Chugai Pharmaceutical Co. Ltd., Chugai's attorneys said Thursday the settlement netted their client $775 million.

Source: law360.com